Literature DB >> 22788737

Editorial: cancer chemoresistance and DNA repair.

Simone Mocellin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22788737     DOI： 10.2174/092986712802002545

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN： 0929-8673            Impact factor:   4.530


× No keyword cloud information.
  1 in total

1.  RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy.

Authors:  Ali Flores-Pérez; Lourdes E Rafaelli; Nayeli Ramírez-Torres; Elena Aréchaga-Ocampo; Sara Frías; Silvia Sánchez; Laurence A Marchat; Alfredo Hidalgo-Miranda; Valeria Quintanar-Jurado; Sergio Rodríguez-Cuevas; Verónica Bautista-Piña; Angeles Carlos-Reyes; César López-Camarillo
Journal:  Cancer Biol Ther       Date:  2014-03-18       Impact factor: 4.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.